Analysed VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) News Sources
How The Vanda Pharmaceuticals (VNDA) Investment Story Is Shifting With BYSANTI And Nereus
18-05-2026
yahoo.com
Charcot-Marie-Tooth Disease Market Growth to Accelerate Significantly During the Forecast Period (2026-2036) Driven by the Launch of Emerging Disease-Modifying Therapies | DelveInsight
21-05-2026
yahoo.com
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis
27-05-2026
yahoo.com
Insomnia Market Witnesses Robust Growth During the Forecast Period (2026-2036) with Emerging Orexin Receptor Antagonists and Melatonin Receptor Agonist | DelveInsight
18-06-2026
yahoo.com
Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S
07-07-2026
yahoo.com
VNDA Stock Gains After-Hours As FDA Grants Rare Pediatric Disease Designation For Experimental Therapy
08-07-2026
stocktwits.com
Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit
10-07-2026
yahoo.com
NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment
15-07-2026
yahoo.com
What is the current price of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The current price of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is $5.12.
VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) since the previous trading day is $-0.1.
VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) since the previous trading day is -1.9157%.
What is the most recent average sentiment score for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The most recent average sentiment score for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)?
The most recent sentiment for VANDA PHARMACEUTICALS INC (VNDA:NASDAQ) is .
SEC-8K** Filing Available For VANDA PHARMACEUTICALS INC (VNDA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.